To evaluate the efficacy of ronidazole for treatment of Tritrichomonas foetus infection, 6 Tritrichomonas-free kittens were experimentally infected with a Korean isolate of T. foetus. The experimental infection was confirmed by direct microscopy, culture, and single-tube nested PCR, and all cats demonstrated trophozoites of T. foetus by day 20 post-infection in the feces. From day 30 after the experimentally induced infection, 3 cats were treated with ronidazole (50 mg/kg twice a day for 14 days) and 3 other cats received placebo. Feces from each cat were tested for the presence of T. foetus by direct smear and culture of rectal swab samples using modified Diamond's medium once a week for 4 weeks. To confirm the culture results, the presence of T. foetus rRNA gene was determined by single-tube nested PCR assay. All 3 cats in the treatment group receiving ronidazole showed negative results for T. foetus infection during 2 weeks of treatment and 4 weeks follow-up by all detection methods used in this study. In contrast, rectal swab samples from cats in the control group were positive for T. foetus continuously throughout the study. The present study indicates that ronidazole is also effective to treat cats infected experimentally with a Korean isolate of T. foetus at a dose of 50 mg/kg twice a day for 14 days.
Tritrichomonas foetus is a flagellated protozoan parasite that colonizes the ileum, cecum, and colon, causing colitis and chro nic large bowel diarrhea in cats [1] . Infected cats may have per sistent diarrhea as long as 2 years and may remain infected for life, although spontaneous resolution of diarrhea may occur [2] . In the Republic of Korea, the first clinical case of feline in testinal tritrichomoniasis was reported in our previous study [3] . We also found that 6.8% (5/73) of surveyed cats in Korea were infected with T. foetus (paper submitted).
To date, the only known effective drug for T. foetus is ronida zole [1] , which is currently not approved for use in compan ion animals [4] . However, the chemicalgrade powder is avail able and the drug can be formulated into either tablets or cap sules by pharmacies [5] . Ronidazole, a 5nitroimidazole, killed T. foetus in vitro [6] and eliminated T. foetus from experimen tally infected cats at doses ranging from 30 to 50 mg/kg orally twice a day for 14 days [1] . At lower doses (10 mg/kg PO orally twice a day for 14 days), ronidazole has been ineffective at elim inating T. foetus infection [1] . The purpose of this study was to evaluate the efficacy of ronidazole for treatment of cats experi mentally infected with a Korean isolate of T. foetus, on the ba sis of culture and PCR testing of rectal swab samples.
T. foetus was originally isolated from a naturally infected fe male Siamese cat in our previous study [3] . Trophozoites were successfully subcultured in modified Diamond's medium (Re mel, Lenexa, Kansas, USA) in the laboratory and the Korean isolate (YG 1) was used for experimental inoculation in this study.
Five to seven monthold female (n= 2) and male (n= 4) do mestic Korean shorthair cats were purchased from a local mar ket for experimental infection with T. foetus. Each cat was con firmed to be free of T. foetus and Giardia spp. by direct fecal smear, rectal swab culture in modified Diamond's medium, and a singletube nested PCR assay as described previously [7] . All cats were additionally examined for the presence of Giardiaspecific antigen using commercial Giardia antigen test kit (SNAP TM Giardia, IDEXX Laboratories, Westbrook, Maine, USA). Cats were randomly divided into 2 equal groups; 3 for treat ment and 3 for control. Each cat was sedated with aceproma zine maleate (0.05 mg/kg, IM), atropine sulfate (0.04 mg/kg, SC), and a combination of tiletamine and zolazepam (5 mg/ kg, IM), and received 360 µl of media containing approximate ly 2,000,000 live T. foetus trophozoites through a feeding tube. Infection with T. foetus was confirmed by direct microscopy and singletube nested PCR testing as described previously [7] . After 7 days of oral inoculation, rectal swab samples of each cat were suspended in saline and examined microscopically daily until motile trophozoites of T. foetus were observed. All 6 cats demonstrated trophozoites of T. foetus by day 20 postin fection (PI) in the feces.
From day 30 after the experimentally induced infection, treat ment with ronidazole was initiated. Three cats in the treatment group were treated with oral administration of ronidazole at 50 mg/kg twice a day for 14 days, and 3 other cats belonging to the control group received empty capsules. Chemical grade ronidazole ([1methyl5nitroimidazole2yl]methyl carba mate; 99% pure, R76355G; Sigma Chemical Co, St. Louis, Missouri, USA) was compounded into gel capsules for use in this study. Fecal samples from each cat were tested for the pres ence of T. foetus trophozoites by direct smear and culture of rectal swab samples using modified Diamond's medium (Re mel Media; Remel) once a week for 4 weeks. To confirm the culture results, the presence of T. foetus rRNA gene was deter mined by singletube nested PCR assay using a combination of TFITSF/TFITSR and TFR3/TFR4 primers as described previ ously [7] .
All cats were confirmed to be free of T. foetus before experi mentally induced infection by direct smear and singletube nest ed PCR test of rectal swab samples (data not shown). Some of the cats started to reveal T. foetus trophozoites in rectal samples at day 7 after inoculation, and all cats were positive by day 20 PI (Table 1; Fig. 1A) . No cat showed signs of diarrhea after ex perimentally induced infection in this study.
All 3 cats in the treatment group receiving ronidazole showed negative results for T. foetus infection during 2 weeks of treat ment and 4 weeks followup by all detection methods used in this study. In contrast, rectal swab samples from each untreat ed cat (control group) were positive for T. foetus continuously throughout the study (Table 2; Fig. 1B) .
Currently, there is no effective commerciallyavailable drug against intestinal T. foetus infection in cats. Metronidazole has often been used as an initial choice of drug against feline in testinal trichomoniasis, but organisms were hardly eliminated, and diarrhea resumed shortly after the last medication with the drug [1] . Ronidazole is reported to be the only known ef fective treatment for T. foetus [8] . Oral administration of roni dazole at 3050 mg/kg twice a day for 14 days resolved diar rhea and eradicated T. foetus [1] . We therefore evaluated the ef ficacy of ronidazole at 50 mg/kg twice a day for 14 days for treatment of cats experimentally infected with a Korean isolate of T. foetus.
As has been reported previously [1] , cats experimentally in fected with a Korean isolate of T. foetus were also successfully treated with ronidazole at 50 mg/kg twice a day for 14 days. Trophozoites were not detected from cats in the treatment group by all detection methods used in this study, including PCR as say from 1 week posttreatment, whereas cats belonging the control group showed T. foetuspositive continuously through out the study period after infection. However, the duration of followup in the present study was much shorter than that of the previous study [1] , in which repeated PCR testing was per formed over durations of 2130 weeks to confirm eradication of the infection in cats. The authors observed that infection could relapse as long as 20 weeks after the treatment, and thus shortterm studies of drug efficacy in T. foetus infected cats should be viewed with caution [1] .
Unfortunately, we were unable to observe the effects of roni dazole treatment on diarrhea in the experimentally infected cats, because diarrhea was not observed from any of the 6 cats before or during the treatment period. The reason for the ab sence of diarrhea in the cats is not known, but this observation is consistent with previous studies on experimental infections [1, 8, 9] . Gookin et al. [8] suggested the possibility of strain dif ferences in the pathogenicity of T. foetus, as has been reported for Trichomonas vaginalis [8, 10] . Further studies are needed re garding the mechanisms of the pathogenicity of T. foetus in cats.
Another possibility is the difference in susceptibility by breed of cats. According to some previous studies, pedigree cats ap pear to be more frequently infected with T. foetus than mixed bred cats [11, 12] , although many other researchers did not de scribe the same conclusion [1215] . In our previous study on the prevalence of T. foetus in cats in Korea, we found only 1.9% (1/53) of nonpedigree domestic cats was positive, while 50% (2/4) and 11% (1/9) of Siamese and Persian breeds of cats were positive, respectively (paper submitted). However, it is difficult to draw conclusions regarding the association between T. foetus and breed of cats in the study because of the small number of cats surveyed. A high rate of T. foetus infection among specific breeds of cats, including Siamese cats, was also reported in a previous study in the UK [11] .
The present study indicates that ronidazole is effective to treat cats infected experimentally with a Korean isolate of T. foetus at a dose of 50 mg/kg twice a day for 14 days. Although no reports are available on the differences in susceptibility by different isolates to chemotherapy, the potential presence of different strains/isolates and a rather narrow choice of drug to treat feline tritrichomoniasis indicate that the susceptibility of the Korean isolates of T. foetus to ronidazole needs to be evalu ated. Treatment  C-30  ------------C-45  ------------C-77  ------------Control  C- A direct smear and culture of rectal swab samples were carried out once a week during the 2 weeks of treatment period and for 4 weeks after the termination of the last treatment.
a From 30 days after inoculation, 3 cats treatment group were treated with ronidazole (Sigma-Aldrich) at 50 mg/kg twice a day for 14 days, and the remaining 3 cats received placebo. DS, direct smear; C, culture in modified Diamond's medium.
